The Claim
In patients with treated Graves' disease, non-suppressibility of thyroidal iodine uptake following T3 administration indicates the presence of thyroid autonomy or thyroid-stimulating substances other than TSH, despite TSH suppression.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients treated for Graves' disease, thyroid iodine uptake does not decrease as expected after T3 administration, indicating the presence of autonomous thyroid activity or non-TSH substances that stimulate the thyroid.
See the scientific wording
In patients with treated Graves' disease, the non-suppressibility of thyroidal iodine uptake after T3 administration may reflect either thyroid autonomy or the presence of thyroid-stimulating substances other than TSH, as TSH suppression can occur without corresponding suppression of iodine uptake.
Antibodies bind to the thyroid gland's TSH receptors and keep them permanently turned on, so the thyroid keeps taking up iodine and making hormones even when the brain stops sending TSH signals.
What the research says
1 studyEven when a hormone (T3) shuts down the brain’s signal to the thyroid (TSH), the thyroid in some Graves’ patients still grabs iodine like normal — this suggests the thyroid is either acting on its own or being fooled by another signal.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.